Dr. Garren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-498-5710- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1994 - 1997
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1993 - 1994
- David Geffen School of Medicine at UCLAClass of 1993
Certifications & Licensure
- CA State Medical License 1994 - 2026
Publications & Presentations
PubMed
- 5 citationsMyelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a.Shannon Kolind, Shawna Abel, Carolyn Taylor, Roger Tam, Cornelia Laule, David K B Li, Hideki Garren, Laura Gaetano, Corrado Bernasconi, David Clayton, Irene Vavasour, ...> ;Neuroimage. Clinical. 2022 Jan 1
- 198 citationsSafety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAnthony Traboulsee, Benjamin Greenberg, Jeffrey Bennett, Lech Szczechowski, Edward Fox, Svitlana Shkrobot, Takashi Yamamura, Y Terada, Yuichi Kawata, Padraig Wright, A...> ;The Lancet. Neurology. 2020 May 1
- 5 citationsMagnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1aErin L. MacMillan, Julia Schubert, Irene M. Vavasour, Roger Tam, Alexander Rauscher, Carolyn Taylor, Richard A. White, Hideki Garren, David Clayton, Victoria Levesque,...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019 Oct 15
- Join now to see all
Press Mentions
- Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical TrialApril 13th, 2023
- Biotech Company Prothena Taps Walgreens to Recruit Patients for Alzheimer's Drug ResearchApril 13th, 2023
- Prothena Corporation Plc (NASDAQ:PRTA) Q4 2022 Earnings Call TranscriptFebruary 28th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: